Studies have shown that FGFR1 gene amplification is present in 9.3% to 17.4% of patients with squamous head and neck cell carcinoma (HNSCC), while 11.8% of patients exhibit FGFR1 protein overexpression [25]. Here, FGFR1 is linked to head and neck squamous cell carcinoma.